USA – How shoddy science is fueling a charge to restrict abortion pill access

The FDA has been tasked with re-evaluating the safety of mifepristone after a flawed report claimed it has a high rate of serious complications.

May 19, 2025
By Aria Bendix

Health and Human Services Secretary Robert F. Kennedy Jr. has tasked the Food and Drug Administration with conducting a safety review of mifepristone, a pill used in most U.S. abortions. Kennedy said this week that the review was warranted due to an “alarming” new report on serious adverse events released last month.

“Clearly it indicates that, at very least, the label should be changed,” he told Sen. Josh Hawley, R-Mo., at a Senate budget hearing on Wednesday. “I’ve asked Marty Makary, who’s the director of FDA, to do a complete review and to report back.”

Continued: https://www.nbcnews.com/health/womens-health/shoddy-science-fueling-charge-restrict-abortion-pill-access-rcna207034

20.05.2025

Commentary

abortion pills

anti-choice fake science

fake science

Food and Drug Administration

Josh Hawley

Marty Makary

Robert F. Kennedy Jr.

United States

Anti-choice

Human Rights

Junk science is cited in abortion ban cases. Researchers are fighting the ‘fatally flawed’ work

Researchers are calling for the retraction of misleading anti-abortion studies that could influence judges in critical cases

Jessica Glenza
Sun 28 Apr 2024

The retraction of three peer-reviewed articles prominently cited in court cases on the so-called abortion pill – mifepristone – has put a group of papers by anti-abortion researchers in the scientific limelight.

Seventeen sexual and reproductive health researchers are calling for four peer-reviewed studies by anti-abortion researchers to be retracted or amended. The papers, critics contend, are “fatally flawed” and muddy the scientific consensus for courts and lawmakers who lack the scientific training to understand their methodological flaws.

Continued: https://www.theguardian.com/world/2024/apr/28/junk-science-papers-abortion-cases

Supreme Court mifepristone case will affect millions. Don’t base ruling off junk science.

Access to safe and effective medications like mifepristone should be based on rigorous scientific research and the medical community consensus – not the fringe opinions of a few extremists.

Julia Kaye
Jan 31, 2024

Overturning Roe v. Wade was just the beginning.

In Idaho v. United States, the question is whether states can disregard longstanding federal protections and bar doctors from providing abortions to patients experiencing medical emergencies.

The second case, Alliance for Hippocratic Medicine v. Food and Drug Administration, targets access to mifepristone, a safe and effective medication used in most abortions in this country and for miscarriage management. Since its FDA approval a quarter century ago, mifepristone has been safely used by more than 5 million people.

Continued: https://www.usatoday.com/story/opinion/voices/2024/01/31/supreme-court-abortion-pill-mifepristone-junk-science/72370445007/

Trump fetal tissue ethics board urges rejection of nearly all research proposals

By Amy Goldstein
August 18, 2020

A new advisory board, created to review the ethics of proposed fetal tissue research grants, is urging the Trump administration to block government funding for nearly all of the applications — essentially seeking to ban support for most such scientific work.

The recommendation that the National Institutes of Health withhold funds
from all but one of a slate of 14 research proposals means that Health and
Human Services Secretary Alex Azar, who has the final say, would need to buck
the will of a board he convened — and of social conservatives crucial to
President Trump’s political base — for the projects to get federal support.

Continued: https://www.washingtonpost.com/health/trump-fetal-tissue-research/2020/08/18/85902fcc-e157-11ea-8dd2-d07812bf00f7_story.html